Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMedicx Fund Regulatory News (MXF)

  • There is currently no data for MXF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - MedicX Fund Limited

25 Jan 2019 08:43

RNS Number : 1227O
Numis Securities Limited
25 January 2019
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Numis Securities Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

MedicX Fund Limited

(c) Name of the party to the offer with which exempt principal trader is connected:

Primary Health Properties Plc

(d) Date dealing undertaken:

24/01/2019

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

Primary Health Properties Plc

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary NPV

Purchase

600,256

87.00 GBX

84.96 GBX

Ordinary NPV

Sale

1,913,441

86.80 GBX

85.00 GBX

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

Date of disclosure:

25/01/2019

Contact name:

Conor Clarke

Telephone number:

0207 260 1600

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEREAPFSALFNEEF
Date   Source Headline
29th Jan 201910:06 amRNSForm 8.5 (EPT/RI) - MedicX Fund Limited
29th Jan 20198:20 amRNSForm 8.5 (EPT/RI) - MedicX Fund Limited
28th Jan 20193:30 pmRNSForm 8.3 - MedicX Fund Ltd
28th Jan 20193:20 pmRNSForm 8.3 - MedicX Fund Limited
28th Jan 20192:21 pmRNSForm 8.3 - MedicX Fund Limited
28th Jan 20191:54 pmRNSForm 8.3 - MedicX Fund Ltd.
28th Jan 20191:41 pmRNSForm 8.3 - Primary Health Properties plc
28th Jan 20191:38 pmRNSForm 8.3 - MedicX Fund Limited
28th Jan 201911:55 amRNSForm 8.5 (EPT/RI) - MedicX Fund Limited
28th Jan 201911:20 amRNSForm 8.3 - Primary Health Properties plc
28th Jan 201911:00 amRNSForm 8.3 - Primary Health Properties Plc
28th Jan 201910:56 amRNSForm 8.3 - MedicX Fund Limited
28th Jan 20198:45 amRNSForm 8.5 (EPT/RI)
28th Jan 20198:32 amRNSForm 8.5 (EPT/RI) - MedicX Fund Limited
25th Jan 20194:00 pmRNSForm 8.3 - Medicx Fund Ltd
25th Jan 20193:20 pmRNSForm 8.3 - MedicX Fund Limited
25th Jan 20193:07 pmEQSForm 8.3 - The Vanguard Group, Inc.: MedicX Fund Limited
25th Jan 20192:33 pmGNWForm 8.3 - MedicX Fund Limited
25th Jan 20191:56 pmRNSForm 8.3 - Primary Health Properties plc
25th Jan 20191:36 pmRNSForm 8.3 - MedicX Fund Limited
25th Jan 20191:27 pmRNSForm 8.3 Disclosure
25th Jan 201912:16 pmRNSForm 8.3 - MedicX Fund Limited
25th Jan 201912:00 pmRNSForm 8.5 (EPT/RI)
25th Jan 201912:00 pmRNSForm 8.5 (EPT/RI) Primary Health Properties PLC
25th Jan 201911:30 amRNSForm 8.3 - Primary Health Properties plc
25th Jan 201910:45 amRNSForm 8.5 (EPT/RI) - MedicX Fund Limited
25th Jan 20199:54 amRNSForm 8.3 - [Medix Fund Ltd ORD]
25th Jan 20199:41 amRNSForm 8.5 (EPT/RI)
25th Jan 20198:43 amRNSForm 8.5 (EPT/RI) - MedicX Fund Limited
24th Jan 20193:14 pmRNSForm 8.3 - Primary Health Properties plc
24th Jan 20193:09 pmRNSForm 8.3 - MedicX Fund Limited
24th Jan 20197:00 amRNSRECOMMENDED ALL-SHARE MERGER OF PHP & MEDICX FUND
11th Dec 20187:00 amRNSResults for the year ended 30 September 2018
22nd Nov 20183:00 pmRNSScrip Dividend Alternative - Suspension
1st Nov 20185:31 pmRNSNotice of dividend
1st Oct 20189:00 amRNSAllotment of scrip shares and total voting rights
1st Oct 20187:00 amRNSUpdated Key Information Document
27th Sep 20183:24 pmRNSTR-1 Notification of major holdings
17th Sep 20185:43 pmRNSSecurities allotted from Block Listing
12th Sep 20184:41 pmRNSScrip Dividend Declaration and total voting rights
11th Sep 20185:42 pmRNS£264.5m refinancing of Aviva debt facilities
6th Sep 201812:37 pmRNSTR-1 Notification of major holdings
28th Aug 20181:34 pmRNSScrip Calculation Price
21st Aug 20183:28 pmRNSPublication of Circular - Scrip Dividend Scheme
1st Aug 20187:00 amRNSNotice of Dividend
23rd Jul 20187:12 amRNSTrading Update and Quarterly NAV Announcement
18th Jul 20184:35 pmRNSTR-1 Notification of major holdings
12th Jul 20182:41 pmRNSDirector Declaration
2nd Jul 20183:21 pmRNSAllotment of Scrip Shares
25th Jun 20185:18 pmRNSNotification of major holding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.